Release Date: 28/02/11 15:30 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 11.38MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%